Mucosal and Cutaneous Human Papillomavirus Infections and Cancer Biology.
Papillomavirus
anogenital cancer
infection and cancer
skin cancer
transformation
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2019
2019
Historique:
received:
10
01
2019
accepted:
17
04
2019
entrez:
29
5
2019
pubmed:
28
5
2019
medline:
28
5
2019
Statut:
epublish
Résumé
Papillomaviridae is a family of small non-enveloped icosahedral viruses with double-stranded circular DNA. More than 200 different human papillomaviruses (HPVs) have been listed so far. Based on epidemiological data, a subgroup of alphapapillomaviruses (alpha HPVs) was referred to as high-risk (HR) HPV types. HR HPVs are the etiological agents of anogenital cancer and a subset of head and neck cancers. The cutaneous HPV types, mainly from beta and gamma genera, are widely present on the surface of the skin in the general population. However, there is growing evidence of an etiological role of betapapillomaviruses (beta HPVs) in non-melanoma skin cancer (NMSC), together with ultraviolet (UV) radiation. Studies performed on mucosal HR HPV types, such as 16 and 18, showed that both oncoproteins E6 and E7 play a key role in cervical cancer by altering pathways involved in the host immune response to establish a persistent infection and by promoting cellular transformation. Continuous expression of E6 and E7 of mucosal HR HPV types is essential to initiate and to maintain the cellular transformation process, whereas expression of E6 and E7 of cutaneous HPV types is not required for the maintenance of the skin cancer phenotype. Beta HPV types appear to play a role in the initiation of skin carcinogenesis, by exacerbating the accumulation of UV radiation-induced DNA breaks and somatic mutations (the hit-and-run mechanism), and they would therefore act as facilitators rather than direct actors in NMSC. In this review, the natural history of HPV infection and the transforming properties of various HPV genera will be described, with a particular focus on describing the state of knowledge about the role of cutaneous HPV types in NMSC.
Identifiants
pubmed: 31134154
doi: 10.3389/fonc.2019.00355
pmc: PMC6517478
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
355Références
J Gen Virol. 1999 Jun;80 ( Pt 6):1513-7
pubmed: 10374970
J Virol. 1999 Aug;73(8):6209-19
pubmed: 10400710
Nature. 1999 Jul 1;400(6739):29-30
pubmed: 10403244
Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8449-54
pubmed: 10411895
Int J Cancer. 1999 Sep 9;82(6):775-81
pubmed: 10446440
Oncogene. 1999 Sep 30;18(40):5487-96
pubmed: 10523825
Semin Cancer Biol. 1999 Dec;9(6):423-30
pubmed: 10712889
Biochem Biophys Res Commun. 2000 Apr 21;270(3):903-9
pubmed: 10772923
Virology. 2000 Apr 25;270(1):124-34
pubmed: 10772985
J Natl Cancer Inst. 2000 May 3;92(9):690-8
pubmed: 10793105
J Virol. 2000 Oct;74(20):9680-93
pubmed: 11000240
Mol Cell Biol. 2000 Nov;20(21):8244-53
pubmed: 11027293
Arch Virol. 2000;145(10):2183-91
pubmed: 11087100
J Virol. 2000 Dec;74(24):11636-41
pubmed: 11090162
Oncogene. 2000 Nov 30;19(51):5884-91
pubmed: 11127819
J Virol. 2002 Jan;76(1):220-31
pubmed: 11739687
J Clin Microbiol. 2002 Mar;40(3):886-91
pubmed: 11880410
J Biol Chem. 2002 Jun 14;277(24):21730-9
pubmed: 11934887
Virology. 2002 Mar 30;295(1):97-107
pubmed: 12033769
Cancer Causes Control. 2002 Nov;13(9):839-46
pubmed: 12462549
J Virol. 2003 Mar;77(5):2819-31
pubmed: 12584305
Oncogene. 2003 Feb 27;22(8):1225-37
pubmed: 12606949
J Clin Microbiol. 2003 Jun;41(6):2509-14
pubmed: 12791874
Oncogene. 2003 Jun 19;22(25):3833-41
pubmed: 12813456
Oncogene. 2003 Sep 4;22(38):5938-45
pubmed: 12955072
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4549-53
pubmed: 1316611
J Virol. 1992 Oct;66(10):6070-80
pubmed: 1326657
Mol Cell Biol. 2003 Nov;23(22):8352-62
pubmed: 14585992
J Virol. 2004 Feb;78(4):2100-13
pubmed: 14747575
Intervirology. 2004;47(1):48-56
pubmed: 15044836
J Biol Chem. 2004 Jun 11;279(24):25729-44
pubmed: 15073179
Virology. 2004 Jun 20;324(1):17-27
pubmed: 15183049
Microbiol Mol Biol Rev. 2004 Jun;68(2):362-72
pubmed: 15187189
Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14252-7
pubmed: 15383670
J Virol. 2004 Nov;78(22):12366-77
pubmed: 15507623
J Virol. 2004 Dec;78(24):13613-26
pubmed: 15564472
FASEB J. 2005 Jan;19(1):115-7
pubmed: 15629897
Mol Cell. 2005 Jan 21;17(2):251-64
pubmed: 15664194
J Virol. 2005 Apr;79(7):4229-37
pubmed: 15767424
Cancer Res. 2005 Mar 15;65(6):2216-23
pubmed: 15781634
J Invest Dermatol. 2005 Jul;125(1):93-7
pubmed: 15982308
Cancer Res. 2005 Aug 1;65(15):6534-42
pubmed: 16061632
Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11492-7
pubmed: 16061792
Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15093-8
pubmed: 16214886
EMBO Rep. 2006 Mar;7(3):334-40
pubmed: 16397624
J Gen Virol. 2006 Feb;87(Pt 2):287-94
pubmed: 16432013
Int J Cancer. 2006 Oct 15;119(8):1878-85
pubmed: 16708385
Int J Oncol. 2006 Sep;29(3):541-8
pubmed: 16865269
Oncogene. 2007 Jan 25;26(4):487-99
pubmed: 16878151
J Virol. 2006 Sep;80(18):8940-50
pubmed: 16940506
Vaccine. 2006 Aug 31;24 Suppl 3:S3/52-61
pubmed: 16950018
J Virol. 2006 Oct;80(19):9530-43
pubmed: 16973557
J Invest Dermatol. 2007 Jan;127(1):116-9
pubmed: 17024097
Diagn Cytopathol. 2006 Nov;34(11):739-48
pubmed: 17041957
J Cell Sci. 2006 Dec 1;119(Pt 23):4857-65
pubmed: 17105772
J Virol. 2007 Feb;81(3):1379-89
pubmed: 17121805
Virology. 2007 Apr 10;360(2):447-53
pubmed: 17125811
Mol Cell. 2006 Dec 28;24(6):867-76
pubmed: 17189189
Apoptosis. 2007 Mar;12(3):549-60
pubmed: 17195958
J Virol. 2007 Apr;81(8):4116-29
pubmed: 17267478
J Virol. 2007 Apr;81(8):3786-96
pubmed: 17267499
J Virol. 2007 Apr;81(7):3618-26
pubmed: 17267502
Br J Dermatol. 2007 May;156(5):1078-80
pubmed: 17381450
Science. 2007 Mar 30;315(5820):1850-3
pubmed: 17395830
J Gen Virol. 2007 May;88(Pt 5):1489-95
pubmed: 17412978
Exp Dermatol. 2007 Jul;16(7):590-9
pubmed: 17576239
J Virol. 2007 Sep;81(17):9419-25
pubmed: 17596310
J Virol. 2007 Sep;81(18):9737-47
pubmed: 17609271
Lancet. 2007 Jul 7;370(9581):59-67
pubmed: 17617273
Biochemistry. 2007 Sep 11;46(36):10279-86
pubmed: 17705400
Lancet. 2007 Sep 8;370(9590):890-907
pubmed: 17826171
J Gen Virol. 2007 Oct;88(Pt 10):2670-8
pubmed: 17872518
J Exp Med. 2008 Jan 21;205(1):35-42
pubmed: 18158319
Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):189-95
pubmed: 18199724
J Clin Oncol. 2008 Feb 1;26(4):612-9
pubmed: 18235120
J Virol. 2008 Apr;82(8):3894-902
pubmed: 18256157
Nature. 2008 Mar 13;452(7184):225-9
pubmed: 18311128
J Virol. 2008 Jun;82(11):5127-36
pubmed: 18353941
Cell Death Differ. 2008 Jul;15(7):1187-95
pubmed: 18483491
Laryngoscope. 2008 Jul;118(7):1236-47
pubmed: 18496162
Mol Cell Biol. 2008 Aug;28(15):4819-28
pubmed: 18505829
PLoS Pathog. 2008 Jun 20;4(6):e1000091
pubmed: 18566657
J Virol. 2008 Sep;82(17):8695-705
pubmed: 18579589
Curr Top Microbiol Immunol. 2008;321:59-83
pubmed: 18727487
Int J Cancer. 2008 Nov 15;123(10):2260-6
pubmed: 18752251
J Virol. 2008 Nov;82(21):10841-53
pubmed: 18753207
PLoS Pathog. 2008 Sep 05;4(9):e1000148
pubmed: 18773072
Am J Transplant. 2008 Nov;8(11):2199-204
pubmed: 18785959
J Virol. 2009 Jan;83(2):811-6
pubmed: 18987132
Virology. 2009 Jan 5;383(1):60-8
pubmed: 18996550
Oncogene. 2008 Nov 24;27(55):7031-46
pubmed: 19029943
Virology. 2009 Feb 20;384(2):324-34
pubmed: 19081593
J Virol. 2009 Apr;83(7):2907-16
pubmed: 19153227
PLoS Pathog. 2009 Feb;5(2):e1000318
pubmed: 19247434
J Gen Virol. 2009 Jul;90(Pt 7):1611-21
pubmed: 19321753
Carcinogenesis. 2009 May;30(5):753-7
pubmed: 19321801
Int J Cancer. 2009 Jul 15;125(2):362-6
pubmed: 19330833
Lancet Oncol. 2009 Apr;10(4):321-2
pubmed: 19350698
Cancer Res. 2009 May 1;69(9):3828-32
pubmed: 19401452
Cancer Treat Res. 2009;146:143-57
pubmed: 19415200
J Med Virol. 2009 Aug;81(8):1444-9
pubmed: 19551818
Cancer Res. 2009 Jul 15;69(14):5656-63
pubmed: 19584294
Int J Cancer. 2010 Feb 1;126(3):684-91
pubmed: 19609952
J Investig Dermatol Symp Proc. 2009 Aug;14(1):63-6
pubmed: 19675557
Virology. 2009 Oct 10;393(1):135-43
pubmed: 19712955
J Gen Virol. 2010 Feb;91(Pt 2):521-30
pubmed: 19812262
Int J Cancer. 2010 Jun 1;126(11):2614-21
pubmed: 19856311
J Exp Med. 1935 Sep 30;62(4):523-48
pubmed: 19870432
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20458-63
pubmed: 19920181
J Invest Dermatol. 2010 Mar;130(3):841-8
pubmed: 19924140
J Cell Biol. 1991 Mar;112(5):785-95
pubmed: 1999457
Carcinogenesis. 2010 Mar;31(3):402-10
pubmed: 20015862
PLoS One. 2010 Jan 13;5(1):e8667
pubmed: 20084279
Virology. 2010 Apr 25;400(1):44-52
pubmed: 20144468
Virology. 2010 May 10;400(2):233-9
pubmed: 20189212
Vaccine. 2010 Apr 26;28(19):3269-72
pubmed: 20226244
Cancer Res. 2010 May 15;70(10):4081-91
pubmed: 20442284
Gynecol Oncol. 2010 Jun;118(1 Suppl):S12-7
pubmed: 20494219
Nat Rev Cancer. 2010 Aug;10(8):550-60
pubmed: 20592731
Cancer Res. 2010 Sep 1;70(17):6913-24
pubmed: 20663910
Proc Natl Acad Sci U S A. 1978 Mar;75(3):1537-41
pubmed: 206906
Trends Microbiol. 2010 Oct;18(10):432-8
pubmed: 20739182
Virology. 2011 Jan 20;409(2):348-59
pubmed: 21074234
Cancer Res. 2010 Dec 1;70(23):9777-86
pubmed: 21098702
J Virol. 2011 Feb;85(4):1757-64
pubmed: 21123374
Mol Biol Evol. 2011 Jul;28(7):2101-13
pubmed: 21285031
Mol Cell Biol. 2011 Jun;31(11):2210-26
pubmed: 21482671
J Invest Dermatol. 2011 Aug;131(8):1745-53
pubmed: 21490616
Virology. 2011 Jun 5;414(2):153-63
pubmed: 21492895
Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1315-21
pubmed: 21527576
EMBO J. 1990 Jan;9(1):153-60
pubmed: 2153075
J Med Virol. 2011 Aug;83(8):1345-50
pubmed: 21678438
J Virol. 2011 Aug;85(16):8208-16
pubmed: 21680517
J Virol. 2011 Sep;85(18):9447-58
pubmed: 21734036
J Virol. 2011 Oct;85(19):9984-97
pubmed: 21752901
Cell. 1990 Dec 21;63(6):1129-36
pubmed: 2175676
J Am Acad Dermatol. 2011 Aug;65(2):253-261
pubmed: 21763561
Med Microbiol Immunol. 2012 May;201(2):117-25
pubmed: 21792749
Virol J. 2011 Aug 01;8:379
pubmed: 21806797
PLoS Pathog. 2011 Aug;7(8):e1002211
pubmed: 21901101
PLoS One. 2011;6(11):e27655
pubmed: 22110707
Traffic. 2012 Mar;13(3):455-67
pubmed: 22151726
Oncogene. 1990 Sep;5(9):1383-9
pubmed: 2216461
J Virol. 2012 Feb;86(4):2366-70
pubmed: 22171257
Oncogene. 2012 Oct 25;31(43):4639-46
pubmed: 22249263
Indian J Hum Genet. 2011 Sep;17(3):132-44
pubmed: 22345983
J Virol. 2012 May;86(9):5341-51
pubmed: 22357280
Int J Cancer. 2013 Jan 1;132(1):63-71
pubmed: 22514107
PLoS Pathog. 2012;8(4):e1002657
pubmed: 22536154
Curr Opin Virol. 2012 Aug;2(4):459-66
pubmed: 22658985
Blood. 2012 Jul 26;120(4):822-32
pubmed: 22689861
Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10516-21
pubmed: 22689991
Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1303-13
pubmed: 22707711
J Virol. 2012 Sep;86(18):9875-87
pubmed: 22761365
PLoS One. 2012;7(6):e39632
pubmed: 22761851
Head Neck Pathol. 2012 Jul;6 Suppl 1:S3-15
pubmed: 22782219
PLoS Pathog. 2012;8(7):e1002807
pubmed: 22807682
J Clin Virol. 2012 Nov;55(3):250-5
pubmed: 22884670
Virology. 2012 Nov 10;433(1):216-9
pubmed: 22925336
J Virol. 2012 Dec;86(24):13313-23
pubmed: 23015707
Int J Mol Med. 2013 Jan;31(1):120-8
pubmed: 23128250
Br J Cancer. 2013 Jan 15;108(1):240-4
pubmed: 23169278
J Virol. 2013 Feb;87(3):1586-95
pubmed: 23175360
Vaccine. 2012 Nov 20;30 Suppl 5:F55-70
pubmed: 23199966
Virology. 2013 Jan 5;435(1):57-69
pubmed: 23217616
J Natl Cancer Inst. 2013 Mar 6;105(5):350-60
pubmed: 23291375
Int J Gynecol Cancer. 2013 Feb;23(2):235-43
pubmed: 23314283
Infect Agent Cancer. 2013 Jan 23;8(1):4
pubmed: 23343041
J Virol. 2013 Apr;87(8):4762-7
pubmed: 23365452
Viruses. 2013 May 30;5(6):1374-94
pubmed: 23722886
Virology. 2013 Oct;445(1-2):138-68
pubmed: 23731972
J Clin Oncol. 2013 Jul 20;31(21):2708-15
pubmed: 23775966
PLoS One. 2013 Jun 18;8(6):e66693
pubmed: 23824673
Radiother Oncol. 2013 Sep;108(3):397-402
pubmed: 23830197
Virology. 2013 Oct;445(1-2):57-79
pubmed: 23849793
J Infect Dis. 2013 Oct 15;208(8):1335-41
pubmed: 23878325
Infect Agent Cancer. 2013 Aug 30;8(1):31
pubmed: 24000898
J Virol. 2013 Nov;87(22):12158-65
pubmed: 24006432
Int J Cancer. 2014 May 1;134(9):2231-44
pubmed: 24136717
MBio. 2013 Nov 05;4(6):e00845-13
pubmed: 24194542
PLoS Pathog. 2013 Oct;9(10):e1003717
pubmed: 24204267
J Clin Virol. 2013 Dec;58(4):652-9
pubmed: 24210970
Virology. 2014 Jan 5;448:356-62
pubmed: 24314666
J Virol. 2014 Apr;88(8):4514-21
pubmed: 24501412
PLoS Pathog. 2014 Feb 20;10(2):e1003924
pubmed: 24586150
PLoS One. 2014 Feb 24;9(2):e88718
pubmed: 24586376
J Am Podiatr Med Assoc. 2014 Mar;104(2):141-6
pubmed: 24725033
PLoS Pathog. 2014 May 15;10(5):e1004117
pubmed: 24832099
PLoS Pathog. 2014 May 29;10(5):e1004162
pubmed: 24874089
J Clin Virol. 2014 Sep;61(1):101-6
pubmed: 25011603
PLoS One. 2014 Aug 20;9(8):e104374
pubmed: 25140695
Expert Rev Anti Infect Ther. 2014 Oct;12(10):1165-70
pubmed: 25199987
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15544-9
pubmed: 25313082
Int J Cancer. 2015 Jun 1;136(11):2546-55
pubmed: 25388227
Int J Cancer. 2015 Jun 15;136(12):2831-43
pubmed: 25408501
J Mol Biol. 2014 Dec 12;426(24):4030-4048
pubmed: 25451029
Presse Med. 2014 Dec;43(12 Pt 2):e435-43
pubmed: 25451638
EMBO J. 1989 Dec 20;8(13):4099-105
pubmed: 2556261
Sci Rep. 2015 Jan 07;5:7653
pubmed: 25563170
Evol Med Public Health. 2015 Jan 28;2015(1):32-51
pubmed: 25634317
J Med Virol. 2015 Jun;87(6):1022-33
pubmed: 25648229
PLoS Pathog. 2015 Feb 18;11(2):e1004699
pubmed: 25693203
J Virol. 2015 May;89(9):4980-91
pubmed: 25694599
Virology. 2015 May;479-480:290-6
pubmed: 25724416
PLoS One. 2015 Mar 20;10(3):e0119566
pubmed: 25793388
PLoS Pathog. 2015 Mar 24;11(3):e1004687
pubmed: 25803638
J Virol. 2015 Jul;89(14):7038-52
pubmed: 25926655
Virol J. 2015 Jul 07;12:104
pubmed: 26148509
Viruses. 2015 Jul 16;7(7):3863-90
pubmed: 26193301
J Virol. 2015 Oct;89(20):10145-55
pubmed: 26202251
Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):9872-7
pubmed: 26216987
Int J Cancer. 2016 Jan 15;138(2):386-95
pubmed: 26239888
J Virol. 2015 Oct;89(20):10680-7
pubmed: 26269181
PLoS One. 2015 Sep 16;10(9):e0138628
pubmed: 26375679
Int J Cancer. 2016 Mar 1;138(5):1163-74
pubmed: 26417997
Mol Cancer. 2015 Oct 29;14:183
pubmed: 26511842
Nature. 2016 Jan 28;529(7587):541-5
pubmed: 26789255
JAMA Oncol. 2016 May 1;2(5):599-606
pubmed: 26794505
Oncogene. 2016 Aug 25;35(34):4529-39
pubmed: 26804167
Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):721-4
pubmed: 26908428
J Med Virol. 2016 Sep;88(9):1646-51
pubmed: 26945813
Expert Rev Vaccines. 2016 Oct;15(10):1327-36
pubmed: 27063030
PLoS Pathog. 2016 Apr 11;12(4):e1005556
pubmed: 27064408
J Virol. 2016 Jun 24;90(14):6224-6234
pubmed: 27122588
Cancer. 2016 Aug 1;122(15):2313-23
pubmed: 27152637
Cancer Res. 2016 Jul 15;76(14):4216-25
pubmed: 27216183
Postepy Dermatol Alergol. 2016 Apr;33(2):75-80
pubmed: 27279814
J Virol. 2016 Aug 26;90(18):8032-5
pubmed: 27412595
J Virol. 2016 Sep 12;90(19):8768-79
pubmed: 27440877
Lancet Glob Health. 2016 Sep;4(9):e609-16
pubmed: 27470177
PLoS Pathog. 2016 Aug 02;12(8):e1005766
pubmed: 27483446
J Clin Virol. 2016 Sep;82:159-165
pubmed: 27500365
Sci Rep. 2016 Sep 08;6:33028
pubmed: 27604338
MBio. 2016 Sep 20;7(5):
pubmed: 27651363
Virology. 2017 Jan;500:71-81
pubmed: 27771561
J Virol. 2016 Dec 16;91(1):
pubmed: 27795438
J Biomed Sci. 2016 Nov 4;23(1):75
pubmed: 27809842
Virus Res. 2017 Mar 2;231:96-102
pubmed: 27825778
Virology. 2017 Jan;500:218-225
pubmed: 27829177
Virus Res. 2017 Mar 2;231:128-138
pubmed: 27856220
MBio. 2016 Nov 22;7(6):
pubmed: 27879331
J Gen Virol. 2016 Dec;97(12):3291-3301
pubmed: 27902363
PLoS One. 2017 Jan 5;12(1):e0169533
pubmed: 28056100
J Virol. 2017 Mar 13;91(7):
pubmed: 28100625
Nature. 2017 Mar 16;543(7645):378-384
pubmed: 28112728
Oncotarget. 2017 Mar 14;8(11):17684-17699
pubmed: 28187443
BMC Cancer. 2017 Feb 15;17(1):136
pubmed: 28202002
J Natl Cancer Inst. 2017 Aug 1;109(8):
pubmed: 28376197
Gynecol Oncol. 2017 Jul;146(1):196-204
pubmed: 28442134
Oncotarget. 2017 Apr 18;8(16):26515-26531
pubmed: 28460446
Int J Cancer. 2017 Aug 1;141(3):540-548
pubmed: 28470669
J Gen Virol. 2017 Apr;98(4):715-725
pubmed: 28475030
Open Forum Infect Dis. 2017 Jan 31;4(1):ofw216
pubmed: 28480229
J Infect Dis. 2017 Jul 1;216(1):92-96
pubmed: 28549147
J Virol. 2017 Jul 27;91(16):null
pubmed: 28566382
J Invest Dermatol. 2017 Oct;137(10):2208-2216
pubmed: 28595997
PLoS Pathog. 2017 Jun 22;13(6):e1006406
pubmed: 28640877
Br J Dermatol. 2018 Jan;178(1):253-260
pubmed: 28646591
JAMA Dermatol. 2017 Sep 1;153(9):892-896
pubmed: 28700773
Virology. 2017 Oct;510:55-59
pubmed: 28708973
Biomedicines. 2017 Jul 30;5(3):null
pubmed: 28758953
Curr Opin Virol. 2017 Oct;26:56-62
pubmed: 28778034
Arch Pharm Res. 2017 Sep;40(9):1050-1063
pubmed: 28875439
Cell. 2017 Sep 7;170(6):1164-1174.e6
pubmed: 28886384
Nat Cell Biol. 2017 Oct;19(10):1214-1225
pubmed: 28892079
Front Microbiol. 2017 Sep 08;8:1724
pubmed: 28970821
Am J Transplant. 2018 May;18(5):1220-1230
pubmed: 29024374
Papillomavirus Res. 2016 Dec;2:70-77
pubmed: 29074188
PLoS Pathog. 2017 Nov 30;13(11):e1006723
pubmed: 29190285
Oral Oncol. 2017 Dec;75:106-110
pubmed: 29224806
Papillomavirus Res. 2018 Jun;5:46-58
pubmed: 29277575
PLoS Pathog. 2017 Dec 27;13(12):e1006781
pubmed: 29281732
PLoS Pathog. 2018 Jan 11;14(1):e1006783
pubmed: 29324843
Sci Rep. 2018 Jan 16;8(1):811
pubmed: 29339794
J Virol. 2018 Mar 14;92(7):
pubmed: 29367246
Int J Cancer. 2018 Jun 15;142(12):2491-2500
pubmed: 29377141
Oncol Lett. 2018 Feb;15(2):2278-2286
pubmed: 29434935
Virology. 2018 Jun;519:1-11
pubmed: 29609071
Papillomavirus Res. 2018 Jun;5:150-155
pubmed: 29660489
Virology. 2018 Jun;519:74-76
pubmed: 29679790
Virology. 2018 Jul;520:1-10
pubmed: 29747121
Sci Rep. 2018 May 29;8(1):8241
pubmed: 29844517
J Virol. 2018 Jul 17;92(15):null
pubmed: 29848583
J Infect Dis. 2018 Jul 2;218(3):388-397
pubmed: 29982800
J Exp Med. 2018 Sep 3;215(9):2289-2310
pubmed: 30068544
Cancer Epidemiol Biomarkers Prev. 2018 Oct;27(10):1168-1175
pubmed: 30087123
Antiviral Res. 2018 Oct;158:113-121
pubmed: 30096339
Int J Mol Sci. 2018 Sep 04;19(9):null
pubmed: 30181457
PLoS Biol. 2018 Oct 25;16(10):e2005752
pubmed: 30359362
mSphere. 2018 Dec 12;3(6):
pubmed: 30541782
Int J Cancer. 2019 Aug 1;145(3):785-796
pubmed: 30719706
MBio. 2019 Feb 19;10(1):
pubmed: 30782659
Hum Genet. 1984;67(2):136-42
pubmed: 6430783
J Gen Virol. 1995 May;76 ( Pt 5):1239-45
pubmed: 7730808
Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1654-8
pubmed: 7878034
J Virol. 1994 Nov;68(11):7051-9
pubmed: 7933087
Oncogene. 1994 Jul;9(7):1869-76
pubmed: 8208532
Cell. 1993 Nov 5;75(3):495-505
pubmed: 8221889
Mol Cell Biol. 1993 Aug;13(8):4918-27
pubmed: 8393140
J Virol. 1996 Mar;70(3):1912-22
pubmed: 8627717
Oncogene. 1996 Jun 6;12(11):2325-30
pubmed: 8649772
Virology. 1996 Sep 1;223(1):251-4
pubmed: 8806560
Science. 1997 Jan 3;275(5296):73-7
pubmed: 8974395
Genes Dev. 1997 Aug 15;11(16):2090-100
pubmed: 9284048
Genes Dev. 1997 Aug 15;11(16):2101-11
pubmed: 9284049
EMBO J. 1998 Dec 1;17(23):7044-55
pubmed: 9843509